Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Construction in Progress (2016 - 2025)

Standard Biotools (LAB) has disclosed Construction in Progress for 15 consecutive years, with $375000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Construction in Progress fell 93.97% to $375000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $375000.0, a 93.97% decrease, with the full-year FY2024 number at $6.0 million, up 158.27% from a year prior.
  • Construction in Progress was $375000.0 for Q3 2025 at Standard Biotools, down from $473000.0 in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $22.0 million in Q3 2021 to a low of $375000.0 in Q3 2025.
  • A 5-year average of $5.8 million and a median of $3.1 million in 2023 define the central range for Construction in Progress.
  • Peak YoY movement for Construction in Progress: soared 19369.03% in 2021, then plummeted 93.97% in 2025.
  • Standard Biotools' Construction in Progress stood at $4.5 million in 2021, then plummeted by 64.56% to $1.6 million in 2022, then skyrocketed by 44.79% to $2.3 million in 2023, then soared by 158.27% to $6.0 million in 2024, then tumbled by 93.78% to $375000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Construction in Progress are $375000.0 (Q3 2025), $473000.0 (Q2 2025), and $7.0 million (Q1 2025).